CODEINE PHOSPHATE AND GUAIFENESIN

CODEINE PHOSPHATE AND GUAIFENESIN was reported 107 times

CODEINE PHOSPHATE AND GUAIFENESIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA 1 0.0323
1 LUNG ASSIST DEVICE THERAPY 1 0.0161
2 MALFORMATION VENOUS 1 0.0143
3 MESENTERIC VASCULAR INSUFFICIENCY 1 0.0091
4 BURKHOLDERIA TEST POSITIVE 1 0.0081
5 HANGNAIL 1 0.0058
6 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
7 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
8 BOREDOM 1 0.0029
9 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
10 CAROTID BRUIT 1 0.0026
11 DEPENDENCE ON RESPIRATOR 1 0.0025
12 HYPOXIC ENCEPHALOPATHY 1 0.0024
13 SYSTOLIC HYPERTENSION 1 0.0023
14 OBLITERATIVE BRONCHIOLITIS 3 0.0023
15 DIVORCED 1 0.0023
16 TYPE V HYPERLIPIDAEMIA 1 0.0021
17 WATER INTOXICATION 1 0.0020
18 TRACHEAL DISORDER 1 0.0019
19 EJACULATION DELAYED 1 0.0018
20 ADENOMYOSIS 1 0.0017
21 BRONCHITIS CHRONIC 4 0.0016
22 CONTRAST MEDIA ALLERGY 3 0.0016
23 POST PROCEDURAL DISCHARGE 1 0.0015
24 TUMOUR FLARE 1 0.0015
25 TRAUMATIC FRACTURE 1 0.0014
26 BASOPHIL COUNT INCREASED 1 0.0013
27 TRACHEOBRONCHITIS 1 0.0013
28 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
29 GRANULOMA SKIN 1 0.0012
30 BLOOD MAGNESIUM INCREASED 1 0.0011
31 NEUROPSYCHIATRIC SYMPTOMS 1 0.0011
32 FOREIGN BODY IN EYE 1 0.0010
33 HAEMANGIOMA OF LIVER 1 0.0010
34 OCULAR TOXICITY 1 0.0009
35 INFUSION SITE WARMTH 1 0.0008
36 PULMONARY VALVE INCOMPETENCE 1 0.0007
37 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
38 AMYLOIDOSIS 1 0.0006
39 CONDUCTION DISORDER 1 0.0005
40 TRAUMATIC LUNG INJURY 1 0.0005
41 ULTRAFILTRATION FAILURE 1 0.0005
42 HYPERPHOSPHATAEMIA 1 0.0005
43 INFUSION SITE BRUISING 1 0.0005
44 TEMPERATURE REGULATION DISORDER 1 0.0004
45 PANNICULITIS 1 0.0004
46 AORTIC ARTERIOSCLEROSIS 1 0.0004
47 BREAST SWELLING 1 0.0004
48 GAMBLING DISORDER 1 0.0004
49 ANORGASMIA 1 0.0004
50 RHEUMATOID NODULE 1 0.0004
51 ENDOTRACHEAL INTUBATION 1 0.0004
52 DRUG TOLERANCE DECREASED 1 0.0004
53 EYELID MARGIN CRUSTING 1 0.0003
54 LOSS OF EMPLOYMENT 1 0.0003
55 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
56 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
57 INFUSION SITE PRURITUS 1 0.0003
58 NON-CARDIAC CHEST PAIN 1 0.0003
59 LYMPHOCYTE COUNT INCREASED 1 0.0003
60 INFUSION SITE HAEMORRHAGE 1 0.0003
61 REGURGITATION 1 0.0003
62 BRONCHIOLITIS 1 0.0003
63 ALCOHOL USE 1 0.0003
64 HYDRONEPHROSIS 2 0.0003
65 TRICUSPID VALVE INCOMPETENCE 2 0.0003
66 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
67 CARDIOMEGALY 3 0.0002
68 HYPERURICAEMIA 1 0.0002
69 AORTIC VALVE INCOMPETENCE 1 0.0002
70 CARDIAC MURMUR 2 0.0002
71 LUNG INFILTRATION 2 0.0002
72 ABDOMINAL HERNIA 1 0.0002
73 PERFORMANCE STATUS DECREASED 1 0.0002
74 PULSE ABSENT 1 0.0002
75 BREATH SOUNDS ABNORMAL 1 0.0002
76 HYPERVOLAEMIA 1 0.0002
77 FLUID INTAKE REDUCED 1 0.0002
78 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
79 HYPOPHAGIA 5 0.0002
80 FOETAL DEATH 1 0.0002
81 SKIN NECROSIS 1 0.0002
82 ASPIRATION 2 0.0002
83 MITRAL VALVE INCOMPETENCE 2 0.0002
84 SKIN ATROPHY 1 0.0002
85 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
86 RHEUMATOID FACTOR POSITIVE 1 0.0002
87 HYPERVENTILATION 1 0.0002
88 HYPOVOLAEMIA 1 0.0002
89 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
90 INJECTION SITE VESICLES 1 0.0002
91 OLIGURIA 1 0.0002
92 INFUSION SITE SWELLING 1 0.0002
93 APPETITE DISORDER 1 0.0002
94 SINUS CONGESTION 2 0.0001
95 TACHYPNOEA 2 0.0001
96 BLOOD TESTOSTERONE DECREASED 1 0.0001
97 FAECES SOFT 1 0.0001
98 SENSITIVE SKIN 1 0.0001
99 PSYCHIATRIC SYMPTOM 1 0.0001
100 BREAST TENDERNESS 1 0.0001
101 TENDON PAIN 1 0.0001
102 ACIDOSIS 1 0.0001
103 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
104 FOOD ALLERGY 1 0.0001
105 HAEMOLYSIS 1 0.0001
106 APNOEA 1 0.0001
107 BASAL CELL CARCINOMA 2 0.0001
108 PULMONARY HAEMORRHAGE 1 0.0001
109 MULTIPLE ALLERGIES 1 0.0001
110 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
111 AFFECTIVE DISORDER 1 0.0001
112 RENAL CYST 1 0.0001
113 ATRIAL FLUTTER 1 0.0001
114 RHINITIS 1 0.0001
115 POST PROCEDURAL INFECTION 1 0.0001
116 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
117 VENTRICULAR TACHYCARDIA 2 0.0001
118 HAEMODIALYSIS 1 0.0001
119 INFUSION SITE ERYTHEMA 1 0.0001
120 ANURIA 1 0.0001
121 PYELONEPHRITIS 1 0.0001
122 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
123 HAEMOLYTIC ANAEMIA 1 0.0001
124 UROSEPSIS 1 0.0001
125 LACERATION 1 0.0001
126 HERPES ZOSTER 6 0.0001
127 PULMONARY FIBROSIS 2 0.0001
128 ATELECTASIS 1 0.0001
129 DIZZINESS POSTURAL 1 0.0001
130 COELIAC DISEASE 1 0.0001
131 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
132 VITREOUS FLOATERS 1 0.0001
133 HOSPICE CARE 1 0.0001
134 PERITONITIS BACTERIAL 1 0.0001
135 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
136 SUBARACHNOID HAEMORRHAGE 1 0.0001
137 VENTRICULAR EXTRASYSTOLES 1 0.0001
138 PULMONARY HYPERTENSION 2 0.0001
139 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
140 BREAST PAIN 1 0.0001
141 SKIN LACERATION 1 0.0001
142 TOOTH FRACTURE 1 0.0001
143 INFUSION RELATED REACTION 6 0.0001
144 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
145 SKIN INFECTION 1 0.0001
146 MICTURITION URGENCY 1 0.0001
147 CHOLECYSTECTOMY 1 0.0001
148 COVID-19 PNEUMONIA 1 0.0001
149 CHOLECYSTITIS 1 0.0001
150 HYPERLIPIDAEMIA 1 0.0001
151 BURSITIS 1 0.0001
152 NO THERAPEUTIC RESPONSE 1 0.0001
153 CYTOPENIA 1 0.0001
154 HYPERCALCAEMIA 1 0.0001
155 COLITIS 3 0.0001
156 HAEMATEMESIS 2 0.0001
157 CARDIOVASCULAR DISORDER 2 0.0001
158 INFUSION SITE PAIN 1 0.0001
159 RESPIRATORY TRACT INFECTION 2 0.0001
160 BEDRIDDEN 1 0.0001
161 PULMONARY CONGESTION 1 0.0001
162 IMPAIRED GASTRIC EMPTYING 1 0.0001
163 CORONARY ARTERY OCCLUSION 1 0.0001
164 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
165 CARPAL TUNNEL SYNDROME 1 0.0001
166 SEASONAL ALLERGY 1 0.0001
167 SINUS TACHYCARDIA 1 0.0001
168 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
169 SUBDURAL HAEMATOMA 1 0.0001
170 FLUID OVERLOAD 1 0.0001
171 APATHY 1 0.0001
172 CARDIOMYOPATHY 1 0.0001
173 IMMUNODEFICIENCY 1 0.0001
174 HYPOAESTHESIA ORAL 1 0.0001
175 ECONOMIC PROBLEM 1 0.0001
176 INSURANCE ISSUE 1 0.0001
177 DEVICE RELATED INFECTION 1 0.0001
178 EMOTIONAL DISORDER 2 0.0001
179 BRAIN FOG 1 0.0001
180 ULCER 1 0.0001
181 OBESITY 1 0.0001
182 ABSCESS 1 0.0001
183 DEEP VEIN THROMBOSIS 4 0.0001
184 COAGULOPATHY 1 0.0001
185 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
186 HYPERKALAEMIA 2 0.0001
187 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
188 DRUG ERUPTION 1 0.0001
189 SYNOVITIS 1 0.0001
190 BONE DISORDER 1 0.0001
191 END STAGE RENAL DISEASE 1 0.0001
192 PANCYTOPENIA 3 0.0001
193 THINKING ABNORMAL 1 0.0001
194 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
195 DYSPNOEA EXERTIONAL 2 0.0001
196 BLOOD SODIUM DECREASED 1 0.0001
197 FEELING JITTERY 1 0.0001
198 SLEEP APNOEA SYNDROME 1 0.0001
199 POST PROCEDURAL COMPLICATION 1 0.0001
200 LOWER LIMB FRACTURE 1 0.0001
201 PRESCRIBED OVERDOSE 1 0.0001
202 SINUS DISORDER 1 0.0001
203 PRESCRIBED UNDERDOSE 1 0.0001
204 CARDIAC FAILURE 4 0.0000
205 THROMBOSIS 4 0.0000
206 TASTE DISORDER 1 0.0000
207 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
208 RIB FRACTURE 1 0.0000
209 INJECTION SITE WARMTH 1 0.0000
210 PERITONITIS 1 0.0000
211 TREATMENT FAILURE 4 0.0000
212 POLLAKIURIA 2 0.0000
213 RETCHING 1 0.0000
214 IMPAIRED WORK ABILITY 1 0.0000
215 SKIN CANCER 1 0.0000
216 PRODUCT PRESCRIBING ISSUE 1 0.0000
217 MELAENA 1 0.0000
218 TRANSAMINASES INCREASED 1 0.0000
219 NEPHROLITHIASIS 2 0.0000
220 HYPOKALAEMIA 2 0.0000
221 RASH ERYTHEMATOUS 2 0.0000
222 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
223 DIABETIC KETOACIDOSIS 1 0.0000
224 DRUG INTOLERANCE 4 0.0000
225 RESPIRATORY FAILURE 3 0.0000
226 ATRIAL FIBRILLATION 4 0.0000
227 LUNG DISORDER 2 0.0000
228 BRONCHITIS 3 0.0000
229 ABDOMINAL PAIN LOWER 1 0.0000
230 CHRONIC KIDNEY DISEASE 3 0.0000
231 FLUID RETENTION 2 0.0000
232 HEPATITIS 1 0.0000
233 ERECTILE DYSFUNCTION 1 0.0000
234 SKIN ULCER 1 0.0000
235 HAEMATOMA 1 0.0000
236 DEAFNESS 1 0.0000
237 PANCREATITIS 2 0.0000
238 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
239 CARDIAC FAILURE CONGESTIVE 3 0.0000
240 DRY MOUTH 3 0.0000
241 SKIN LESION 1 0.0000
242 ABNORMAL DREAMS 1 0.0000
243 NECK PAIN 2 0.0000
244 THROMBOCYTOPENIA 4 0.0000
245 HYPONATRAEMIA 2 0.0000
246 RHEUMATOID ARTHRITIS 4 0.0000
247 RED BLOOD CELL COUNT DECREASED 1 0.0000
248 ANGINA PECTORIS 1 0.0000
249 HYPERSOMNIA 1 0.0000
250 ASCITES 1 0.0000
251 TACHYCARDIA 3 0.0000
252 URINARY INCONTINENCE 1 0.0000
253 JOINT SWELLING 4 0.0000
254 HYPERTENSION 7 0.0000
255 CORONARY ARTERY DISEASE 1 0.0000
256 FEELING HOT 2 0.0000
257 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
258 CHEST PAIN 6 0.0000
259 PULMONARY EMBOLISM 3 0.0000
260 NIGHT SWEATS 1 0.0000
261 PNEUMONIA 10 0.0000
262 PSORIASIS 4 0.0000
263 CHOLELITHIASIS 1 0.0000
264 STAPHYLOCOCCAL INFECTION 1 0.0000
265 VIRAL INFECTION 1 0.0000
266 URINARY RETENTION 1 0.0000
267 GAIT INABILITY 1 0.0000
268 EYE PRURITUS 1 0.0000
269 ANGER 1 0.0000
270 HEPATIC ENZYME INCREASED 2 0.0000
271 ABDOMINAL DISTENSION 3 0.0000
272 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
273 CEREBRAL HAEMORRHAGE 1 0.0000
274 CRYING 1 0.0000
275 CONSTIPATION 6 0.0000
276 C-REACTIVE PROTEIN INCREASED 1 0.0000
277 HYPERGLYCAEMIA 1 0.0000
278 PANIC ATTACK 1 0.0000
279 ACCIDENTAL OVERDOSE 1 0.0000
280 SEPSIS 3 0.0000
281 ASTHMA 3 0.0000
282 BLOOD PRESSURE INCREASED 4 0.0000
283 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
284 PLASMA CELL MYELOMA 1 0.0000
285 COUGH 7 0.0000
286 URTICARIA 4 0.0000
287 OSTEOARTHRITIS 1 0.0000
288 HYPERHIDROSIS 3 0.0000
289 RECTAL HAEMORRHAGE 1 0.0000
290 PYREXIA 8 0.0000
291 MUSCULOSKELETAL STIFFNESS 2 0.0000
292 COVID-19 4 0.0000
293 RENAL FAILURE 3 0.0000
294 LIVER DISORDER 1 0.0000
295 PULMONARY OEDEMA 1 0.0000
296 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
297 THERAPY NON-RESPONDER 1 0.0000
298 VISION BLURRED 3 0.0000
299 SKIN DISCOLOURATION 1 0.0000
300 DECREASED APPETITE 5 0.0000
301 BLOOD CHOLESTEROL INCREASED 1 0.0000
302 DYSPHAGIA 2 0.0000
303 COMA 1 0.0000
304 LEUKOPENIA 1 0.0000
305 SYNCOPE 2 0.0000
306 HYPOTENSION 4 0.0000
307 CELLULITIS 1 0.0000
308 ACUTE KIDNEY INJURY 3 0.0000
309 SINUSITIS 2 0.0000
310 HAEMOGLOBIN DECREASED 2 0.0000
311 PERIPHERAL SWELLING 3 0.0000
312 INFLAMMATION 1 0.0000
313 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
314 VOMITING 9 0.0000
315 NERVOUSNESS 1 0.0000
316 SPEECH DISORDER 1 0.0000
317 DEPRESSED MOOD 1 0.0000
318 INSOMNIA 5 0.0000
319 RASH PRURITIC 1 0.0000
320 OEDEMA 1 0.0000
321 TREATMENT NONCOMPLIANCE 1 0.0000
322 DEPENDENCE 1 0.0000
323 HAEMATOCHEZIA 1 0.0000
324 ARTHROPATHY 1 0.0000
325 PAIN 11 0.0000
326 BLISTER 1 0.0000
327 EYE PAIN 1 0.0000
328 CONVULSION 1 0.0000
329 LETHARGY 1 0.0000
330 EYE IRRITATION 1 0.0000
331 SURGERY 1 0.0000
332 NASAL CONGESTION 1 0.0000
333 DISEASE PROGRESSION 2 0.0000
334 THERAPEUTIC RESPONSE DECREASED 1 0.0000
335 SUICIDE ATTEMPT 1 0.0000
336 STOMATITIS 1 0.0000
337 PLEURAL EFFUSION 1 0.0000
338 OEDEMA PERIPHERAL 2 0.0000
339 DISCOMFORT 1 0.0000
340 NASOPHARYNGITIS 3 0.0000
341 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
342 EXPOSURE DURING PREGNANCY 1 0.0000
343 RASH 7 0.0000
344 PRODUCT USE ISSUE 3 0.0000
345 ASTHENIA 6 0.0000
346 PRODUCT DOSE OMISSION 1 0.0000
347 DEHYDRATION 2 0.0000
348 INJECTION SITE PRURITUS 1 0.0000
349 NEUTROPENIA 2 0.0000
350 ERYTHEMA 3 0.0000
351 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
352 INJECTION SITE REACTION 1 0.0000
353 BURNING SENSATION 1 0.0000
354 INJURY 1 0.0000
355 SLEEP DISORDER 1 0.0000
356 FATIGUE 11 0.0000
357 SKIN BURNING SENSATION 1 0.0000
358 NAUSEA 11 0.0000
359 INFECTION 2 0.0000
360 AGITATION 1 0.0000
361 EPISTAXIS 1 0.0000
362 HYPOAESTHESIA 2 0.0000
363 INJECTION SITE SWELLING 1 0.0000
364 BACK PAIN 3 0.0000
365 DEATH 11 0.0000
366 ARTHRITIS 1 0.0000
367 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
368 CARDIAC ARREST 1 0.0000
369 CEREBROVASCULAR ACCIDENT 2 0.0000
370 URINARY TRACT INFECTION 2 0.0000
371 MYOCARDIAL INFARCTION 2 0.0000
372 INTENTIONAL PRODUCT MISUSE 1 0.0000
373 HEADACHE 7 0.0000
374 GASTROINTESTINAL DISORDER 1 0.0000
375 ADVERSE DRUG REACTION 1 0.0000
376 MUSCLE SPASMS 2 0.0000
377 ADVERSE EVENT 1 0.0000
378 DIARRHOEA 7 0.0000
379 HYPERSENSITIVITY 2 0.0000
380 SWELLING 1 0.0000
381 BLOOD GLUCOSE INCREASED 2 0.0000
382 DYSPNOEA 6 0.0000
383 CONTUSION 1 0.0000
384 ALOPECIA 2 0.0000
385 PAIN IN EXTREMITY 3 0.0000
386 DYSPEPSIA 1 0.0000
387 HEART RATE INCREASED 1 0.0000
388 SOMNOLENCE 2 0.0000
389 CONDITION AGGRAVATED 3 0.0000
390 CHEST DISCOMFORT 1 0.0000
391 ABDOMINAL PAIN UPPER 2 0.0000
392 ILLNESS 1 0.0000
393 PLATELET COUNT DECREASED 1 0.0000
394 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
395 FALL 3 0.0000
396 INFLUENZA 1 0.0000
397 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
398 ABDOMINAL PAIN 2 0.0000
399 FEELING ABNORMAL 2 0.0000
400 EMOTIONAL DISTRESS 1 0.0000
401 VISUAL IMPAIRMENT 1 0.0000
402 INJECTION SITE ERYTHEMA 1 0.0000
403 DIZZINESS 4 0.0000
404 LOSS OF CONSCIOUSNESS 1 0.0000
405 DRY SKIN 1 0.0000
406 MEMORY IMPAIRMENT 1 0.0000
407 ARTHRALGIA 3 0.0000
408 WEIGHT DECREASED 2 0.0000
409 MALAISE 3 0.0000
410 PRODUCT DOSE OMISSION ISSUE 2 0.0000
411 DRUG INTERACTION 1 0.0000
412 CONFUSIONAL STATE 1 0.0000
413 DRUG DOSE OMISSION 1 0.0000
414 TOXICITY TO VARIOUS AGENTS 1 0.0000
415 MYALGIA 1 0.0000
416 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
417 DRUG INEFFECTIVE 7 0.0000
418 ANAEMIA 1 0.0000
419 PRURITUS 2 0.0000
420 OVERDOSE 1 0.0000
421 OFF LABEL USE 4 0.0000
422 DEPRESSION 1 0.0000
423 INCORRECT DOSE ADMINISTERED 1 0.0000
424 ANXIETY 1 0.0000